BGM · BGM Group Ltd.
Market Cap
$131.20M
Shares
400.62M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$37.92M
+51.1%
FY2025
Net Income
-$19.94M
-1282.1%
FY2025
Gross Margin
16.64%
+0.2pp
FY2025
Operating Margin
-33.18%
-30.9pp
FY2025
Diluted EPS
-$0.18
+10%
FY2025
Operating Cash Flow
-$2.37M
-535.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| $37.92M | $25.1M | $46.47M | $64.86M | $57.1M | $50.03M | $46.1M | $50.37M | |
| — | — | $99.19K | $24.86K | -$57.67K | -$242.88K | — | — | |
| $31.61M | $20.98M | $44.72M | $58.63M | $51.46M | $42.49M | $36.42M | $42.24M | |
| $6.31M | $4.11M | $1.75M | $6.23M | $5.64M | $7.54M | $9.68M | $8.13M | |
| 16.64% | 16.39% | 3.77% | 9.6% | 9.87% | 15.07% | 21% | 16.15% | |
| $672.67K | $1.36M | $568.47K | $1.22M | $8000 | $54K | $44K | — | |
| $17.49M | $2.72M | $2.83M | $2.15M | $2.26M | — | — | — | |
| $18.22M | $3.32M | $3.79M | $4.13M | $3.25M | $2.73M | $3.5M | $2.16M | |
| $149.44K | $101.85K | $65.69K | $52.03K | $55.78K | $50.27K | $50.35K | $55.96K | |
| $1.46M | $1.24M | $1.14M | $1.22M | $1.2M | $1.11M | $1.19M | $1.25M | |
| -$12.58M | -$563.77K | -$2.61M | $2.1M | $2.39M | $4.81M | $6.18M | $5.97M | |
| -33.18% | -2.25% | -5.62% | 3.24% | 4.18% | 9.62% | 13.4% | 11.86% | |
| -$11.12M | $673.46K | -$1.47M | $3.33M | $3.59M | $5.92M | $7.37M | $7.23M | |
| — | — | — | — | $57.67K | $242.88K | $223.66K | $216.19K | |
| -$7.36M | -$1.57M | -$5.29M | -$541.44K | $975.23K | $994.21K | $763.38K | $174.61K | |
| — | $160.03K | $208.53K | $208.26K | $188.61K | $112.54K | $77.39K | — | |
| -$19.94M | -$2.14M | -$7.9M | $1.56M | $3.36M | $5.81M | $6.94M | $6.15M | |
| $277.79K | -$619.98K | $219.17K | $194.3K | $255.13K | $864.91K | $1.03M | $943.36K | |
| -$19.94M | -$1.44M | -$7.78M | $1.08M | $3.15M | $5.06M | $5.91M | $5.2M | |
| -52.59% | -5.75% | -16.74% | 1.66% | 5.52% | 10.12% | 12.82% | 10.33% | |
| -$274.77K | -$74.33K | -$341.45K | $289.56K | -$44.72K | -$123.27K | $576.16K | $33.1K | |
| -$19.94M | -$1.44M | -$7.78M | $1.08M | — | — | — | — | |
| -$16.08M | -$47.87K | -$8.47M | -$1.83M | $4.61M | $6.2M | $4.57M | $4.59M | |
| USD/shares | -$0.18 | -$0.20 | -$1.08 | $0.15 | $0.45 | $0.85 | $0.90 | — |
| USD/shares | -$0.18 | -$0.20 | -$1.08 | $0.15 | $0.45 | $0.85 | $0.90 | — |
| shares | 113.26M | 7.23M | 7.23M | 7.23M | 6.82M | 6M | 6M | 6M |
| shares | 113.26M | 7.23M | 7.23M | 7.23M | 6.82M | 6M | 6M | 6M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2018–FY2023: $2.52M in dividends.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diversified Pharmaceutical and Allied Products | $23,591,893 | $25,097,951 | $46,471,478 | — | — | — | — |
| Insurance Business | $10,964,800 | — | — | — | — | — | — |
| AI Solutions | $3,362,732 | — | — | — | — | — | — |
| Fertilizer | — | — | — | $1,088,570 | — | — | — |
| Heparin Products and Sausage Casing | — | — | — | $23,460,467 | — | — | — |
| Oxytetracycline, Licorice Products and TCMD | — | — | — | $40,305,988 | — | — | — |
| Fertilizer | — | — | — | — | $486,171 | $701,701 | $549,231 |
| Heparin Products and Sausage Casing | — | — | — | — | $23,162,554 | $16,729,115 | $15,397,503 |
| Oxytetracycline Licorice Products And Tcmd | — | — | — | — | $33,451,159 | $32,602,384 | $30,149,950 |
Key facts
CIK
1779578
CUSIP
G7307E123
13F (30d)
11 filings
11 filers
Visit website
Investor relations